|
|
Volumn 11, Issue 12, 2009, Pages 1571-1573
|
|
Editorial: Pitfalls in health-economic evaluations: The case of cost-effectiveness of prophylactic implantable cardioverter-defibrillator therapy in Belgium
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
BELGIUM;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DEFIBRILLATOR;
DEVICE INFECTION;
ECONOMIC EVALUATION;
EDITORIAL;
EUROPE;
HEALTH CARE COST;
HEART ARREST;
HEART FAILURE;
HEART INFARCTION;
HEART LEFT VENTRICLE FUNCTION;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
IMPLANTATION;
MAJOR CLINICAL STUDY;
MATHEMATICAL MODEL;
POPULATION;
PRIORITY JOURNAL;
PROPHYLAXIS;
PROSTHESIS FAILURE;
QUALITY OF LIFE;
SUDDEN DEATH;
SURVIVAL;
BIOLOGICAL MODEL;
COST BENEFIT ANALYSIS;
COST OF ILLNESS;
ECONOMICS;
FEMALE;
LIFE EXPECTANCY;
MALE;
MIDDLE AGED;
MORTALITY;
NOTE;
PROBABILITY;
RISK ASSESSMENT;
RISK FACTOR;
STATISTICAL MODEL;
STATISTICS;
SURVIVAL RATE;
TREATMENT OUTCOME;
BELGIUM;
COST OF ILLNESS;
COST-BENEFIT ANALYSIS;
DEATH, SUDDEN, CARDIAC;
DEFIBRILLATORS, IMPLANTABLE;
FEMALE;
HEALTH CARE COSTS;
HUMANS;
LIFE EXPECTANCY;
MALE;
MARKOV CHAINS;
MIDDLE AGED;
MODELS, CARDIOVASCULAR;
MODELS, ECONOMIC;
RISK ASSESSMENT;
RISK FACTORS;
SURVIVAL ANALYSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
VENTRICULAR DYSFUNCTION, LEFT;
|
|
EID: 71449102567
PISSN: 10995129
EISSN: 15322092
Source Type: Journal
DOI: 10.1093/europace/eup290 Document Type: Editorial |
|
Times cited : (8)
|
|
References (5)
|
